This is in agreement with results obtained by Habu et al. demonstrating that RYK is required for the WNT-5a-dependent invasive activity of glioma cells [16], and suggests that RYK participates in conferring a more aggressive phenotype. The gene discussed is WNT5A; the disease is central nervous system cancer.